NEWS: ER
DIH Announces Fiscal 2024 Fourth Quarter and Fiscal Year End Financial Results
Positive
Revenue growth of 19% year-over-year to $64.5 million
Device revenue increased by 18% to $51.1 million
Service revenue grew by 20% to $11.1 million
Positive operating cash flow of $5.2 million
Strategic partnership with B. Temia for exclusive licensing of Keego™ Dermoskeleton
Projected revenue growth of 15-20% for fiscal 2025
Revenue growth of 19% year-over-year to $64.5 million
Device revenue increased by 18% to $51.1 million
Service revenue grew by 20% to $11.1 million
Positive operating cash flow of $5.2 million
Strategic partnership with B. Temia for exclusive licensing of Keego™ Dermoskeleton
Projected revenue growth of 15-20% for fiscal 2025
Negative
Q4 2024 revenue decreased by 10.2% to $19.4 million
Gross profit for fiscal 2024 decreased by 2.7%
Selling, general and administrative expenses increased by 12.3%
Issuance of $3.3 million in convertible debentures, potentially diluting shareholders
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment